Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Eli Lilly and Company has agreed to acquire Disarm Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company, in a $1.36-billion deal ($135 million upfront and $1.225 billion in milestones). Disarm Therapeutics is a start-up company...

A roundup of news from the US (Regeneron, Seattle Genetics). US FDA OKs Regeneron’s Ebola Drug The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for treating...

Merck & Co. reports it will construct a new manufacturing facility in North Carolina to expand its production capacity for TICE BCG, a medicine containing live, attenuated mycobacteria, and used for treating certain forms of bladder...

Johnson & Johnson (J&J) reports it will contribute up to an additional $1 billion to an all-in settlement amount to resolve opioid litigation to bring the total settlement amount being provided by the company to $5 billion. Last October...

Takeda and Arrowhead Pharmaceuticals, a Pasadena, California-based biopharmaceutical company, have entered into a collaboration and licensing agreement, in a deal worth up to $1.04 billion, to develop Arrowhead’s ARO-AAT, a RNA interference (RNAi)...

Mallinckrodt has voluntarily initiated Chapter 11 bankruptcy proceedings in the US as part of a plan to reduce the company’s debt by $1.3 billion and resolve potential liabilities relating to opioid litigation. The entities that filed Chapter 11...

The US Food and Drug Administration (FDA) has issued guidance to provide sponsors of requests for emergency use authorization (EUA) for COVID-19 vaccines with recommendations regarding the data and information needed to support the issuance of an...

Johnson & Johnson has announced that the European Commission (EC), acting on behalf of European Union (EU) member states, has approved an advance purchase agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of...

Marksans Pharma, a Mumbai, India-based pharmaceutical company, is voluntarily recalling 76 lots of metformin hydrochloride extended-release (ER) tablets (USP 500 mg and 750 mg) to the consumer level in the US due to some lots exceeding acceptable...